HEADER TRANSFERASE 27-JUL-09 2WOM TITLE CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE TITLE 2 (K103N). COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P66, RESIDUES 588-1147; COMPND 5 SYNONYM: HIV-1 RT; COMPND 6 EC: 2.7.7.49; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: HIV-1 REVERSE TRANSCRIPTASE; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: P51, RESIDUES 588-1027; COMPND 13 SYNONYM: HIV-1 RT; COMPND 14 EC: 2.7.7.49; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 8 ORGANISM_TAXID: 11676; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS AIDS, NON-NUCLEOSIDE INHIBITOR, DRUG DESIGN, TRANSFERASE, NNRTI, SBDD EXPDTA X-RAY DIFFRACTION AUTHOR C.PHILLIPS,S.L.IRVING,T.KNOECHEL,H.RINGROSE REVDAT 5 20-DEC-23 2WOM 1 REMARK REVDAT 4 20-JUN-18 2WOM 1 JRNL REMARK REVDAT 3 29-JAN-14 2WOM 1 REMARK VERSN REVDAT 2 29-SEP-10 2WOM 1 JRNL REVDAT 1 11-AUG-10 2WOM 0 JRNL AUTH R.CORBAU,J.MORI,C.PHILLIPS,L.FISHBURN,A.MARTIN,C.MOWBRAY, JRNL AUTH 2 W.PANTON,C.SMITH-BURCHNELL,A.THORNBERRY,H.RINGROSE, JRNL AUTH 3 T.KNOCHEL,S.IRVING,M.WESTBY,A.WOOD,M.PERROS JRNL TITL LERSIVIRINE, A NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR JRNL TITL 2 WITH ACTIVITY AGAINST DRUG-RESISTANT HUMAN IMMUNODEFICIENCY JRNL TITL 3 VIRUS TYPE 1. JRNL REF ANTIMICROB. AGENTS V. 54 4451 2010 JRNL REF 2 CHEMOTHER. JRNL REFN ESSN 1098-6596 JRNL PMID 20660667 JRNL DOI 10.1128/AAC.01455-09 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.9.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 23079 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1184 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2773 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2836 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2636 REMARK 3 BIN R VALUE (WORKING SET) : 0.2824 REMARK 3 BIN FREE R VALUE : 0.3047 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.94 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 137 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7919 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 72.63 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.44940 REMARK 3 B22 (A**2) : 5.27600 REMARK 3 B33 (A**2) : -7.72540 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.641 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.891 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.862 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8152 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 11076 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2841 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 229 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1109 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 8152 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1054 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 9495 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 0.98 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.21 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.33 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2WOM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1290040562. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23100 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 1FKP REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.70000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 77.70000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 58.30000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 77.15000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 58.30000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 77.15000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 77.70000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 58.30000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 77.15000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 77.70000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 58.30000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 77.15000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LYS 690 TO ASN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, LYS 690 TO ASN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 559 REMARK 465 LEU A 560 REMARK 465 PRO B 1 REMARK 465 ILE B 2 REMARK 465 TRP B 88 REMARK 465 GLU B 89 REMARK 465 VAL B 90 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 LYS B 431 REMARK 465 GLU B 432 REMARK 465 PRO B 433 REMARK 465 ILE B 434 REMARK 465 VAL B 435 REMARK 465 GLY B 436 REMARK 465 ALA B 437 REMARK 465 GLU B 438 REMARK 465 THR B 439 REMARK 465 PHE B 440 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 558 CA C O CB CG CD CE REMARK 470 LYS A 558 NZ REMARK 470 MET B 230 CG SD CE REMARK 470 TYR B 232 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 430 CA C O CB CG CD OE1 REMARK 470 GLU B 430 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 14 -75.64 -20.56 REMARK 500 LYS A 20 56.85 -143.95 REMARK 500 THR A 69 54.40 -108.62 REMARK 500 PHE A 87 -166.30 -113.39 REMARK 500 TRP A 88 -90.29 -70.45 REMARK 500 GLU A 89 122.71 160.86 REMARK 500 VAL A 111 29.18 -69.05 REMARK 500 ALA A 114 -81.59 -41.92 REMARK 500 ILE A 135 98.71 -31.63 REMARK 500 ASN A 136 35.02 77.06 REMARK 500 GLU A 138 -81.52 -69.93 REMARK 500 MET A 184 -119.27 55.62 REMARK 500 ILE A 195 -73.16 -3.14 REMARK 500 LYS A 219 -76.31 22.58 REMARK 500 MET A 230 52.09 28.76 REMARK 500 PRO A 243 115.88 -36.18 REMARK 500 SER A 251 116.45 72.91 REMARK 500 THR A 286 -65.53 26.34 REMARK 500 LYS A 287 -21.00 61.37 REMARK 500 GLN A 334 104.10 -53.35 REMARK 500 PRO A 345 107.90 -31.52 REMARK 500 PHE A 346 5.04 82.29 REMARK 500 ALA A 355 47.47 -157.35 REMARK 500 ARG A 356 -151.81 -77.21 REMARK 500 MET A 357 94.28 24.04 REMARK 500 ARG A 358 33.47 -41.70 REMARK 500 ALA A 360 36.91 -68.76 REMARK 500 HIS A 361 108.88 65.47 REMARK 500 TRP A 410 116.34 -166.26 REMARK 500 PRO A 412 -179.55 -60.29 REMARK 500 LEU A 491 -48.37 -9.08 REMARK 500 ARG A 557 73.25 46.20 REMARK 500 GLN B 85 80.77 133.87 REMARK 500 ASP B 86 -78.65 53.21 REMARK 500 LEU B 92 78.84 -103.81 REMARK 500 MET B 184 -126.17 53.27 REMARK 500 VAL B 245 114.19 76.98 REMARK 500 ILE B 270 -60.02 -100.20 REMARK 500 VAL B 276 -4.37 -144.67 REMARK 500 PRO B 313 -106.65 -46.36 REMARK 500 VAL B 314 110.24 -177.30 REMARK 500 PHE B 346 -29.66 79.74 REMARK 500 ARG B 358 103.99 -34.68 REMARK 500 HIS B 361 -0.34 -49.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZZE A 1558 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ODW RELATED DB: PDB REMARK 900 NATIVE HIV-1 PROTEINASE REMARK 900 RELATED ID: 1HVR RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1 ) PROTEASE COMPLEXED REMARK 900 WITH XK263 OF DUPONT MERCK REMARK 900 RELATED ID: 1RTH RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HIV-1 REVERSE TRANSCRIPTASE; CHAIN: A, B; REMARK 900 SYNONYM: HIV-1 RT; EC: 2.7.7.49; ENGINEERED: YES REMARK 900 RELATED ID: 1BWA RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH XV638 OF REMARK 900 DUPONT PHARMACEUTICALS REMARK 900 RELATED ID: 1REV RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1C0T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+ REMARK 900 21.1326 REMARK 900 RELATED ID: 1S1X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1BVG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR MINIMIZED AVERAGE REMARK 900 STRUCTURE REMARK 900 RELATED ID: 1VRU RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HIV-1 REVERSE TRANSCRIPTASE; CHAIN: A, B; REMARK 900 SYNONYM: HIV-1 RT; EC: 2.7.7.49; ENGINEERED: YES REMARK 900 RELATED ID: 1RT5 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10 REMARK 900 RELATED ID: 1DMP RELATED DB: PDB REMARK 900 STRUCTURE OF HIV-1 PROTEASE COMPLEX REMARK 900 RELATED ID: 1BWB RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (V82F/I84V) DOUBLE MUTANT COMPLEXED WITH SD146 OF REMARK 900 DUPONT PHARMACEUTICALS REMARK 900 RELATED ID: 1G6L RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF TETHERED HIV-1 PROTEASE REMARK 900 RELATED ID: 1TL1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW451211 REMARK 900 RELATED ID: 1LWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1BV9 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (I84V) COMPLEXED WITH XV638 OF DUPONT PHARMACEUTICALS REMARK 900 RELATED ID: 1RT3 RELATED DB: PDB REMARK 900 AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH REMARK 900 1051U91 REMARK 900 RELATED ID: 1RTJ RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HIV-1 REVERSE TRANSCRIPTASE; CHAIN: A, B; REMARK 900 SYNONYM: HIV-1 RT; EC: 2.7.7.49; ENGINEERED: YES REMARK 900 RELATED ID: 1S1T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH UC-781 REMARK 900 RELATED ID: 1JLC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH PETT-2 REMARK 900 RELATED ID: 1T05 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE- PRIMERWITH REMARK 900 TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE REMARK 900 RELATED ID: 1HVH RELATED DB: PDB REMARK 900 NONPEPTIDE CYCLIC CYANOGUANIDINES AS HIV PROTEASE INHIBITORS REMARK 900 RELATED ID: 1HXB RELATED DB: PDB REMARK 900 HIV-1 PROTEINASE COMPLEXED WITH RO 31-8959 REMARK 900 RELATED ID: 1JLQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 739W94 REMARK 900 RELATED ID: 1JLA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH TNK-651 REMARK 900 RELATED ID: 1RT4 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781 REMARK 900 RELATED ID: 1JLG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH UC-781 REMARK 900 RELATED ID: 1NCP RELATED DB: PDB REMARK 900 RELATED ID: 1FK9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH DMP- REMARK 900 266(EFAVIRENZ ) REMARK 900 RELATED ID: 1JLB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1RT6 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38 REMARK 900 RELATED ID: 1HWR RELATED DB: PDB REMARK 900 MOLECULAR RECOGNITION OF CYCLIC UREA HIV PROTEASE INHIBITORS REMARK 900 RELATED ID: 1RTD RELATED DB: PDB REMARK 900 STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: REMARK 900 IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE REMARK 900 RELATED ID: 1LW0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1A30 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH A TRIPEPTIDE INHIBITOR REMARK 900 RELATED ID: 1QBS RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1S1V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH TNK-651 REMARK 900 RELATED ID: 1EX4 RELATED DB: PDB REMARK 900 HIV-1 INTEGRASE CATALYTIC CORE AND C- TERMINAL DOMAIN REMARK 900 RELATED ID: 1QBR RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1EP4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S- REMARK 900 1153 REMARK 900 RELATED ID: 1QBT RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1C0U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+ REMARK 900 50.0934 REMARK 900 RELATED ID: 1TKT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW426318 REMARK 900 RELATED ID: 1O1W RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE RNASE H DOMAIN OF THE HIV- 1REVERSE REMARK 900 TRANSCRIPTASE IN THE PRESENCE OF MAGNESIUM REMARK 900 RELATED ID: 1DTQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 PETT-1 ( PETT131A94) REMARK 900 RELATED ID: 1DTT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 PETT-2 ( PETT130A94) REMARK 900 RELATED ID: 1JLF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1E6J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN ( P24) IN COMPLEX WITH REMARK 900 FAB13B5 REMARK 900 RELATED ID: 1S1U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1S1W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH UC-781 REMARK 900 RELATED ID: 1RTI RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HIV-1 REVERSE TRANSCRIPTASE; CHAIN: A, B; REMARK 900 SYNONYM: HIV-1 RT; EC: 2.7.7.49; ENGINEERED: YES REMARK 900 RELATED ID: 1FB7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN IN VIVO HIV-1 PROTEASE MUTANT INCOMPLEX REMARK 900 WITH SAQUINAVIR: INSIGHTS INTO THE MECHANISMS OFDRUG RESISTANCE REMARK 900 RELATED ID: 1TKX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW490745 REMARK 900 RELATED ID: 1JKH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH DMP-266( EFAVIRENZ) REMARK 900 RELATED ID: 1TL3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW450557 REMARK 900 RELATED ID: 1QBU RELATED DB: PDB REMARK 900 HIV-1 PROTEASE INHIBITORS WIIH LOW NANOMOLAR POTENCY REMARK 900 RELATED ID: 1LW2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSETRANSCRIPTASE IN REMARK 900 COMPLEX WITH 1051U91 REMARK 900 RELATED ID: 3PHV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (ISOLATE HXB2) REMARK 900 RELATED ID: 1JLE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSETRANSCRIPTASE REMARK 900 RELATED ID: 1RT7 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84 REMARK 900 RELATED ID: 1C1B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 GCA- 186 REMARK 900 RELATED ID: 1RT1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC- REMARK 900 442 REMARK 900 RELATED ID: 1LWE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV- 1 REVERSETRANSCRIPTASE REMARK 900 (RTMN) IN COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1HIV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE (HIV-1 PR) COMPLEX WITH U75875 (NOA-HIS-CHA- REMARK 900 PSI[CH(OH)CH(OH)] VAL-ILE-APY) REMARK 900 RELATED ID: 1KLM RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152 REMARK 900 RELATED ID: 1FKO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV- 1REVERSE REMARK 900 TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ) REMARK 900 RELATED ID: 1RT2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK- REMARK 900 651 REMARK 900 RELATED ID: 1TKZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH REMARK 900 GW429576 REMARK 900 RELATED ID: 1EXQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIV-1 INTEGRASE CATALYTIC COREDOMAIN REMARK 900 RELATED ID: 1ODY RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH AN INHIBITOR LP-130 REMARK 900 RELATED ID: 1LV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE NON-ACTIVE SITE MUTANT OFTETHERED REMARK 900 HIV-1 PROTEASE TO 2.1A RESOLUTION REMARK 900 RELATED ID: 1C1C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH REMARK 900 TNK- 6123 REMARK 900 RELATED ID: 1ESK RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF NCP7 FROM HIV-1 REMARK 900 RELATED ID: 1TAM RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS, NMR, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1BV7 RELATED DB: PDB REMARK 900 COUNTERACTING HIV-1 PROTEASE DRUG RESISTANCE : STRUCTURAL ANALYSIS REMARK 900 OF MUTANT PROTEASES COMPLEXED WITH XV638 AND SD146, CYCLIC UREA REMARK 900 AMIDES WITH BROAD SPECIFICITIES REMARK 900 RELATED ID: 1FKP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV- 1REVERSE REMARK 900 TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE REMARK 900 RELATED ID: 1VRT RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: HIV-1 REVERSE TRANSCRIPTASE; CHAIN: A, B; REMARK 900 SYNONYM: HIV-1 RT; EC: 2.7.7.49; ENGINEERED: YES REMARK 900 RELATED ID: 1LWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE(RTMQ+ REMARK 900 M184V: M41L/D67N/ K70R/M184V/T215Y) IN COMPLEX WITHNEVIRAPINE REMARK 900 RELATED ID: 1BVE RELATED DB: PDB REMARK 900 HIV-1 PROTEASE-DMP323 COMPLEX IN SOLUTION, NMR, 28 STRUCTURES DBREF 2WOM A 1 560 UNP P04585 POL_HV1H2 588 1147 DBREF 2WOM B 1 440 UNP P04585 POL_HV1H2 588 1027 SEQADV 2WOM ASN A 103 UNP P04585 LYS 690 ENGINEERED MUTATION SEQADV 2WOM ASN B 103 UNP P04585 LYS 690 ENGINEERED MUTATION SEQRES 1 A 560 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 560 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 560 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 560 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 560 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 560 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 560 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 560 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS ASN LYS SEQRES 9 A 560 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 560 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 560 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 560 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 560 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 560 PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 560 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 560 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 560 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 560 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 560 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 560 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 560 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 560 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 A 560 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 560 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 560 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 560 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 560 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 560 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 560 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 560 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 560 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 560 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 560 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 560 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 560 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 560 GLY TYR VAL THR ASN ARG GLY ARG GLN LYS VAL VAL THR SEQRES 37 A 560 LEU THR ASP THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 560 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 560 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 560 ALA GLN PRO ASP GLN SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 560 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 560 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 560 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS VAL SEQRES 44 A 560 LEU SEQRES 1 B 440 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 440 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 440 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 440 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 440 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 440 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 440 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 440 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS ASN LYS SEQRES 9 B 440 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 440 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 440 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 440 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 440 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 440 PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 440 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 440 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 440 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 440 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 440 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 440 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 440 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 440 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 B 440 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 440 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 440 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 440 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 440 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 440 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 440 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 440 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 440 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 440 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 440 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 B 440 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE HET ZZE A1558 23 HETNAM ZZE 5-{[3,5-DIETHYL-1-(2-HYDROXYETHYL)-1H-PYRAZOL-4- HETNAM 2 ZZE YL]OXY}BENZENE-1,3-DICARBONITRILE FORMUL 3 ZZE C17 H18 N4 O2 HELIX 1 1 THR A 27 GLU A 44 1 18 HELIX 2 2 PHE A 77 THR A 84 1 8 HELIX 3 3 ALA A 114 VAL A 118 5 5 HELIX 4 4 ASP A 121 LYS A 126 1 6 HELIX 5 5 TYR A 127 ALA A 129 5 3 HELIX 6 6 SER A 156 ASN A 175 1 20 HELIX 7 7 GLN A 197 ARG A 211 1 15 HELIX 8 8 ASP A 218 GLN A 222 5 5 HELIX 9 9 VAL A 254 VAL A 261 1 8 HELIX 10 10 LYS A 263 SER A 268 1 6 HELIX 11 11 VAL A 276 LEU A 283 1 8 HELIX 12 12 THR A 296 GLU A 312 1 17 HELIX 13 13 ASN A 363 TRP A 383 1 21 HELIX 14 14 GLN A 394 TYR A 405 1 12 HELIX 15 15 THR A 473 ASP A 488 1 16 HELIX 16 16 ILE A 505 GLN A 509 5 5 HELIX 17 17 SER A 515 LYS A 528 1 14 HELIX 18 18 GLN A 547 ALA A 554 1 8 HELIX 19 19 THR B 27 GLU B 44 1 18 HELIX 20 20 PHE B 77 THR B 84 1 8 HELIX 21 21 ASP B 113 SER B 117 5 5 HELIX 22 22 PHE B 124 ALA B 129 5 6 HELIX 23 23 SER B 134 GLU B 138 5 5 HELIX 24 24 SER B 156 ASN B 175 1 20 HELIX 25 25 GLN B 197 TRP B 212 1 16 HELIX 26 26 HIS B 235 TRP B 239 5 5 HELIX 27 27 VAL B 254 VAL B 261 1 8 HELIX 28 28 LYS B 263 SER B 268 1 6 HELIX 29 29 VAL B 276 LEU B 283 1 8 HELIX 30 30 THR B 296 GLU B 312 1 17 HELIX 31 31 ASN B 363 TRP B 383 1 21 HELIX 32 32 GLN B 394 TRP B 402 1 9 HELIX 33 33 THR B 403 TYR B 405 5 3 HELIX 34 34 PRO B 420 GLN B 428 1 9 SHEET 1 AA 3 ILE A 47 LYS A 49 0 SHEET 2 AA 3 ARG A 143 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 AA 3 PHE A 130 THR A 131 -1 O PHE A 130 N TYR A 144 SHEET 1 AB 2 VAL A 60 LYS A 65 0 SHEET 2 AB 2 LYS A 70 VAL A 75 -1 O LYS A 70 N LYS A 65 SHEET 1 AC 3 THR A 107 ASP A 110 0 SHEET 2 AC 3 ASP A 186 VAL A 189 -1 O LEU A 187 N LEU A 109 SHEET 3 AC 3 TYR A 181 TYR A 183 -1 O TYR A 181 N TYR A 188 SHEET 1 AD 3 PHE A 227 LEU A 228 0 SHEET 2 AD 3 GLU A 233 LEU A 234 -1 O LEU A 234 N PHE A 227 SHEET 3 AD 3 TRP A 239 THR A 240 -1 O THR A 240 N GLU A 233 SHEET 1 AE 2 TRP A 252 THR A 253 0 SHEET 2 AE 2 VAL A 292 ILE A 293 -1 O ILE A 293 N TRP A 252 SHEET 1 AF 5 LYS A 347 LYS A 350 0 SHEET 2 AF 5 TRP A 337 GLU A 344 -1 O ILE A 341 N LEU A 349 SHEET 3 AF 5 ILE A 326 LYS A 331 -1 O ILE A 326 N TYR A 342 SHEET 4 AF 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 AF 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 AG 5 GLN A 464 VAL A 467 0 SHEET 2 AG 5 ALA A 455 THR A 459 -1 O ALA A 455 N VAL A 467 SHEET 3 AG 5 GLU A 438 TYR A 441 -1 O TYR A 441 N VAL A 458 SHEET 4 AG 5 GLU A 492 THR A 497 1 O GLU A 492 N GLU A 438 SHEET 5 AG 5 LYS A 530 TRP A 535 1 O LYS A 530 N VAL A 493 SHEET 1 BA 3 ILE B 47 LYS B 49 0 SHEET 2 BA 3 ARG B 143 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 BA 3 PHE B 130 THR B 131 -1 O PHE B 130 N TYR B 144 SHEET 1 BB 2 VAL B 60 ILE B 63 0 SHEET 2 BB 2 ARG B 72 VAL B 75 -1 O ARG B 72 N ILE B 63 SHEET 1 BC 4 TYR B 181 TYR B 183 0 SHEET 2 BC 4 ASP B 186 VAL B 189 -1 O ASP B 186 N TYR B 183 SHEET 3 BC 4 VAL B 106 ASP B 110 -1 O THR B 107 N VAL B 189 SHEET 4 BC 4 GLU B 233 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 BD 2 TRP B 252 THR B 253 0 SHEET 2 BD 2 VAL B 292 ILE B 293 -1 O ILE B 293 N TRP B 252 SHEET 1 BE 5 ASN B 348 LYS B 350 0 SHEET 2 BE 5 TRP B 337 TYR B 342 -1 O ILE B 341 N LEU B 349 SHEET 3 BE 5 ILE B 326 LYS B 331 -1 O ILE B 326 N TYR B 342 SHEET 4 BE 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 BE 5 TRP B 414 PHE B 416 1 O GLU B 415 N LEU B 391 CISPEP 1 PRO A 225 PRO A 226 0 1.66 CISPEP 2 PRO A 420 PRO A 421 0 0.66 CISPEP 3 GLN B 85 ASP B 86 0 5.07 SITE 1 AC1 15 PRO A 95 LEU A 100 LYS A 101 LYS A 102 SITE 2 AC1 15 ASN A 103 VAL A 106 VAL A 108 VAL A 179 SITE 3 AC1 15 TYR A 188 PHE A 227 TRP A 229 LEU A 234 SITE 4 AC1 15 HIS A 235 PRO A 236 TYR A 318 CRYST1 116.600 154.300 155.400 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008576 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006481 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006435 0.00000